Skip to content
Screener

Aprea Therapeutics, Inc. APRE Q2 2026 earnings

Reported August 12, 2026 · Before market open

EPS-$0.07Beat by $0.11
Revenue estimate$253.0K
EPS estimate-$0.18

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$307.5K
EPS estimate-$0.08

FAQ

When did Aprea Therapeutics, Inc. report Q2 2026 earnings?
Aprea Therapeutics, Inc. (APRE) reported Q2 2026 earnings on August 12, 2026 before market open.
What were Aprea Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Aprea Therapeutics, Inc. reported eps of $-0.07 for Q2 2026.
Did Aprea Therapeutics, Inc. beat estimates in Q2 2026?
EPS beat the consensus estimate of $-0.18 by $0.11.
How did Aprea Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 86.8% from $-0.53.
Where can I find Aprea Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-094542) and the 10-Q periodic report (0001104659-26-094544) directly on SEC EDGAR. The filing index links above go to sec.gov.